Check out other articles
Scaling cell and gene therapies with DNA synthesis
5 minute read
Synthetic DNA sequences with fewer constraints on sequence complexity are crucial to drive cell and gene therapies forward. Here’s why.
Personalized mRNA vaccines
5 minute read
As the potential of mRNA vaccines to meet a significant, unfulfilled medical demand becomes increasingly clear, we’ll need greater access to gene-length DNA far beyond what’s available right now.
Why are we TdT-free?
3 minute read
In recent years, there has been significant interest in using an enzyme called Terminal deoxynucleotidyl transferase (TdT) to produce synthetic DNA. If we're a cutting-edge DNA synthesis company, why aren't we using TdT?